Harm resulting from screening is likely to be high where prevalence of breast cancer is low

BMJ. 1997 Jul 19;315(7101):190. doi: 10.1136/bmj.315.7101.190.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / prevention & control*
  • False Positive Reactions
  • Female
  • Hong Kong / epidemiology
  • Humans
  • Mass Screening / psychology*
  • Prevalence
  • Program Evaluation